Medical Devices Featured Article

Share
July 16, 2010

Bioject Delivers Infant Vaccines Via Needle-Free Injection


A recent study in The New England Journal of Medicine showed that fractional doses of inactivated poliovirus vaccine could be given to infants safely and effectively by intradermal administration. The needle-free method was preferred by both health care administrators and parents over the usual full-dose needle and syringe. In addition, the study found significant cost savings in use of the fractional-dose intradermal injection over a full-dose vaccination course of treatment.

The intradermal fractional-dose was given with Bioject's Biojector®2000 (B2000) needle-free injection delivery device. Dr. Richard Stout of Bioject said: "based on the findings, as reported in the NEJM, we now have evidence that demonstrates potential cost savings when using intradermal needle-free injection delivery technology as compared with typical full-dose injections. In addition, we along with the parents of the treated infants are delighted to hear that the babies did not cry."

The study took place in Oman, with support by the World Health Organization (WHO) and other sponsors as part of the Global Polio Eradication Initiative (GPEI). The study was in furtherance of GPEI's goal to develop affordable injectable polio vaccine options for the post-eradication era. Results were published in the June 24, 2010 issue of The New England Journal of Medicine (NEJM Vol. 362 No. 25). Via Businesswire.
Get stories like this delivered straight to your inbox. [Free eNews Subscription]

Share



comments powered by Disqus



FREE eNewsletter

Click here to receive your targeted Healthcare Technology Community eNewsletter.
[Subscribe Now]